EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:749681 |
| ChEBI Name | denosumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. antirheumatic drug A drug used to treat rheumatoid arthritis. renoprotective agent Any compound that is able to prevent damage to the kidneys. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. hypoglycemic agent A drug which lowers the blood glucose level. appetite enhancer A drug which increases appetite. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| denosumab (CHEBI:749681) has role antineoplastic agent (CHEBI:35610) |
| denosumab (CHEBI:749681) has role antirheumatic drug (CHEBI:35842) |
| denosumab (CHEBI:749681) has role appetite enhancer (CHEBI:50779) |
| denosumab (CHEBI:749681) has role bone density conservation agent (CHEBI:50646) |
| denosumab (CHEBI:749681) has role gout suppressant (CHEBI:35845) |
| denosumab (CHEBI:749681) has role hypoglycemic agent (CHEBI:35526) |
| denosumab (CHEBI:749681) has role renoprotective agent (CHEBI:231911) |
| denosumab (CHEBI:749681) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| AMG 162 | ChEMBL |
| AMG-162 | ChEMBL |
| AMG162 | ChEMBL |
| Ct-p41 | ChEMBL |
| CTP-41 | ChEMBL |
| CTP41 | ChEMBL |
| Brand Names | Source |
|---|---|
| Prolia | ChEMBL |
| Prolia, ranmark xgeva | ChEMBL |
| Prolia, xgeva | ChEMBL |
| Xgeva | ChEMBL |